Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedDec 17, 2024
DataAggregated Company Financials
Companies18
  • 7D-2.5%
  • 3M-13.2%
  • 1Y-1.0%
  • YTD-4.5%

Over the last 7 days, the Pharma industry has dropped 2.5%, driven by declines in AstraZeneca and GSK of 1.7% and 4.6%, respectively. In contrast, Indivior has gained 6.0%. Over the last year, the industry has been flat overall. As for the next few years, earnings are expected to grow by 20% per annum.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 17 Dec 2024UK£224.3bUK£74.9bUK£7.7b31.5x29x3x
Thu, 14 Nov 2024UK£220.1bUK£74.9bUK£7.7b30.7x28.5x2.9x
Sat, 12 Oct 2024UK£250.3bUK£72.2bUK£9.0b31.1x27.7x3.5x
Mon, 09 Sep 2024UK£271.0bUK£72.0bUK£9.0b40x30.1x3.8x
Wed, 07 Aug 2024UK£262.1bUK£73.3bUK£9.1b37.9x28.9x3.6x
Fri, 05 Jul 2024UK£256.6bUK£71.4bUK£9.5b28.8x26.9x3.6x
Sun, 02 Jun 2024UK£268.8bUK£71.4bUK£9.6b31.8x28.1x3.8x
Tue, 30 Apr 2024UK£262.4bUK£71.6bUK£10.0b32.3x26.2x3.7x
Thu, 28 Mar 2024UK£245.7bUK£70.7bUK£9.8b31.8x25.2x3.5x
Sat, 24 Feb 2024UK£236.1bUK£70.6bUK£9.6b33.7x24.5x3.3x
Mon, 22 Jan 2024UK£238.0bUK£68.9bUK£10.7b36.2x22.3x3.5x
Wed, 20 Dec 2023UK£230.3bUK£68.8bUK£10.7b34.7x21.6x3.3x
Fri, 17 Nov 2023UK£224.4bUK£69.9bUK£10.8b53.4x20.8x3.2x
Sun, 15 Oct 2023UK£245.7bUK£70.8bUK£10.4b56.6x23.7x3.5x
Tue, 12 Sep 2023UK£236.8bUK£69.6bUK£10.2b53.5x23.1x3.4x
Thu, 10 Aug 2023UK£244.1bUK£69.0bUK£10.2b52.8x24x3.5x
Sat, 08 Jul 2023UK£223.4bUK£67.4bUK£7.8b52.7x28.5x3.3x
Mon, 05 Jun 2023UK£250.5bUK£68.6bUK£8.0b55.5x31.4x3.7x
Wed, 03 May 2023UK£255.0bUK£68.5bUK£8.0b55.7x32x3.7x
Fri, 31 Mar 2023UK£241.8bUK£69.4bUK£6.9b51.9x35.2x3.5x
Sun, 26 Feb 2023UK£243.1bUK£70.7bUK£7.1b54.8x34.3x3.4x
Tue, 24 Jan 2023UK£241.6bUK£79.1bUK£6.3b38.5x38.4x3.1x
Thu, 22 Dec 2022UK£245.4bUK£80.1bUK£6.3b37.5x38.7x3.1x
Sat, 19 Nov 2022UK£235.9bUK£80.6bUK£6.4b26.5x37.1x2.9x
Mon, 17 Oct 2022UK£217.1bUK£81.0bUK£3.7b20.3x59.4x2.7x
Wed, 14 Sep 2022UK£232.5bUK£79.2bUK£3.7b15.9x62.8x2.9x
Fri, 12 Aug 2022UK£232.5bUK£77.5bUK£3.8b14.7x61.8x3x
Sun, 10 Jul 2022UK£273.7bUK£75.1bUK£4.5b16.5x60.2x3.6x
Tue, 07 Jun 2022UK£254.8bUK£73.6bUK£4.6b17.1x55.7x3.5x
Thu, 05 May 2022UK£265.9bUK£73.7bUK£4.6b17.6x58.1x3.6x
Sat, 02 Apr 2022UK£255.4bUK£66.6bUK£4.8b20.1x53.2x3.8x
Mon, 28 Feb 2022UK£234.8bUK£65.9bUK£4.8b30.6x49.4x3.6x
Wed, 26 Jan 2022UK£228.6bUK£61.4bUK£5.6b31.9x40.5x3.7x
Fri, 24 Dec 2021UK£233.4bUK£61.6bUK£5.6b31.5x41.3x3.8x
Price to Earnings Ratio

41.3x


Total Market Cap: UK£233.4bTotal Earnings: UK£5.6bTotal Revenue: UK£61.6bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 38x202220232024
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 29.0x which is lower than its 3-year average PE of 38.0x.
  • The 3-year average PS ratio of 3.5x is higher than the industry's current PS ratio of 3.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 11% per year over the last three years.
  • Revenues for these companies have grown 6.8% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market-1.18%
Healthcare-2.31%
Pharma-2.51%
Pharma-2.51%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
INDV IndiviorUK£9.312.5%
+UK£29.0m
-18.8%PS1.3x
REDX Redx PharmaUK£0.1562.2%
+UK£22.4m
-53.8%PS13.9x
DPH Dechra PharmaceuticalsUK£38.660.2%
+UK£6.8m
32.4%PS5.8x
AGY Allergy TherapeuticsUK£0.0641.6%
+UK£4.8m
190.9%PS5.5x
POLB Poolbeg PharmaUK£0.0732.1%
+UK£750.0k
-18.8%PB3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

INDV

UK£9.31

Indivior

7D

2.5%

1Y

-18.8%

GSK

UK£13.34

GSK

7D

-2.9%

1Y

-6.9%

AZN

UK£105.06

AstraZeneca

7D

-0.06%

1Y

1.5%

HCM

UK£2.44

HUTCHMED (China)

7D

-9.6%

1Y

-13.5%

ANA

UK£0.0043

Ananda Developments

7D

3.7%

1Y

30.8%

ANCR

UK£2.42

Animalcare Group

7D

-1.2%

1Y

40.3%

STX

UK£0.028

Shield Therapeutics

7D

-2.7%

1Y

-57.0%

AGY

UK£0.064

Allergy Therapeutics

7D

1.6%

1Y

190.9%

SAR

UK£0.27

Sareum Holdings

7D

1.9%

1Y

-53.0%

INC

UK£0.049

Incanthera

7D

14.1%

1Y

-19.2%

POLB

UK£0.073

Poolbeg Pharma

7D

2.1%

1Y

-18.8%

APH

UK£0.48

Alliance Pharma

7D

-3.8%

1Y

20.2%

DPH

UK£38.66

Dechra Pharmaceuticals

7D

0.2%

1Y

32.4%

REDX

UK£0.15

Redx Pharma

7D

62.2%

1Y

-53.8%